Posttranslational modifications of proteins in type 1, diabetes: The next step in finding the cure?

Diabetes

Volumn 61, Issue 8, 2012, Pages 1907-1914

  Dunne, Jessica L ^a   Overbergh, Lut ^b   Purcell, Anthony W ^c,d   Mathieu, Chantal ^b  

^a Juvenile Diabetes Research Foundation International   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR INTERACTION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; REVIEW;

ANTIGEN PRESENTATION; ANTIGENS; AUTOANTIGENS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNE TOLERANCE; INSULIN-SECRETING CELLS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS;

EID: 84864395040     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1675     Document Type: Review

References (43)

1. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009;5:219-226
2. Eizirik DL, Cnop M. ER stress in pancreatic beta cells: the thin red line between adaptation and failure. Sci Signal 2010;3:pe7
3. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010;140:900-917
4. Ortis F, Naamane N, Flamez D, et al. Cytokines interleukin-1beta and tumor necrosis factor-alpha regulate different transcriptional and alternative splicing networks in primary beta-cells. Diabetes 2010;59:358-374
5. D'Hertog W, Maris M, Ferreira GB, et al. Novel insights into the global proteome responses of insulin-producing INS-1E cells to different degrees of endoplasmic reticulum stress. J Proteome Res 2010;9:5142-5152
6. D'Hertog W, Overbergh L, Lage K, et al. Proteomics analysis of cytokine-induced dysfunction and death in insulin-producing INS-1E cells: new insights into the pathways involved. Mol Cell Proteomics 2007;6:2180-2199
7. van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011;91:79-118
8. Mohan JF, Levisetti MG, Calderon B, Herzog JW, Petzold SJ, Unanue ER. Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat Immunol 2010;11: 350-354
9. Crawford F, Stadinski B, Jin N, et al. Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse. Proc Natl Acad Sci USA 2011;108:16729-16734
10. Stadinski BD, Zhang L, Crawford F, Marrack P, Eisenbarth GS, Kappler JW. Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proc Natl Acad Sci USA 2010;107:10978-10983
11. Stadinski BD, Delong T, Reisdorph N, et al. Chromogranin A is an auto-antigen in type 1 diabetes. Nat Immunol 2010;11:225-231
12. Wu J, Kaufman RJ. From acute ER stress to physiological roles of the Unfolded Protein Response. Cell Death Differ 2006;13:374-384
13. Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 2008;29:42-61 (Pubitemid 351252746)
14. Kaufman RJ, Back SH, Song B, Han J, Hassler J. The unfolded protein response is required to maintain the integrity of the endoplasmic reticulum, prevent oxidative stress and preserve differentiation in β-cells. Diabetes Obes Metab 2010;12(Suppl. 2):99-107
15. Volchuk A, Ron D. The endoplasmic reticulum stress response in the pancreatic β-cell. Diabetes Obes Metab 2010;12(Suppl. 2):48-57
16. Engin F, Hotamisligil GS. Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases. Diabetes Obes Metab 2010;12(Suppl. 2):108-115
17. Sollid LM, Jabri B. Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders. Curr Opin Immunol 2011;23:732-738
18. Tollefsen S, Arentz-Hansen H, Fleckenstein B, et al. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest 2006;116: 2226-2236 (Pubitemid 44162332)
19. Dørum S, Arntzen MO, Qiao SW, et al. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes. PLoS ONE 2010;5:e14056
20. Hovhannisyan Z, Weiss A, Martin A, et al. The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature 2008;456:534-538 (Pubitemid 352759011)
21. Yoshida K, Corper AL, Herro R, Jabri B, Wilson IA, Teyton L. The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity. J Clin Invest 2010;120:1578-1590
22. Luban S, Li ZG. Citrullinated peptide and its relevance to rheumatoid arthritis: an update. Int J Rheum Dis 2010;13:284-287
23. Kidd BA, Ho PP, Sharpe O, et al. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res Ther 2008;10:R119
24. Wood DD, Bilbao JM, O'Connors P, Moscarello MA. Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol 1996;40:18-24 (Pubitemid 26250138)
25. Carrillo-Vico A, Leech MD, Anderton SM. Contribution of myelin auto-antigen citrullination to T cell autoaggression in the central nervous system. J Immunol 2010;184:2839-2846
26. Dogra RS, Vaidyanathan P, Prabakar KR, Marshall KE, Hutton JC, Pugliese A. Alternative splicing of G6PC2, the gene coding for the islet-specific glucose- 6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas. Diabetologia 2006;49:953-957
27. Yip L, Su L, Sheng D, et al. Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes. Nat Immunol 2009;10:1026-1033
28. Mannering SI, Harrison LC, Williamson NA, et al. The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 2005;202:1191-1197 (Pubitemid 41586950)
29. Skowera A, Ellis RJ, Varela-Calviño R, et al. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest 2008;118:3390-3402
30. Roep BO, Arden SD, de Vries RR, Hutton JC. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 1990; 345:632-634
31. Purcell AW, Gorman JJ. Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune response. Mol Cell Proteomics 2004;3:193-208 (Pubitemid 38714276)
32. Tan CT, Croft NP, Dudek NL, Williamson NA, Purcell AW. Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring. Proteomics 2011;11:2336-2340
33. Grünewald J, Hunt GS, Dong L, et al. Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids. Proc Natl Acad Sci USA 2009;106:4337-4342
34. Papini AM. The use of post-translationally modified peptides for detection of biomarkers of immune-mediated diseases. J Pept Sci 2009;15: 621-628
35. Pers TH, Hansen NT, Lage K, et al. Meta-analysis of heterogeneous data sources for genome-scale identification of risk genes in complex phenotypes. Genet Epidemiol 2011;35:318-332
36. Brorsson C, Tue Hansen N, Bergholdt R, Brunak S, Pociot F. The type 1 diabetes - HLA susceptibility interactome - identification of HLA genotype-specific disease genes for type 1 diabetes. PLoS ONE 2010;5:e9576
37. Mannering SI, Pang SH, Williamson NA, et al. The A-chain of insulin is a hot-spot for CD4+ T cell epitopes in human type 1 diabetes. Clin Exp Immunol 2009;156:226-231
38. Knoch KP, Meisterfeld R, Kersting S, et al. cAMP-dependent phosphorylation of PTB1 promotes the expression of insulin secretory granule proteins in beta cells. Cell Metab 2006;3:123-134
39. Myers LK, Myllyharju J, Nokelainen M, et al. Relevance of posttranslational modifications for the arthritogenicity of type II collagen. J Immunol 2004; 172:2970-2975 (Pubitemid 38263684)
40. Kjellén P, Brunsberg U, Broddefalk J, et al. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules. Eur J Immunol 1998;28:755-767 (Pubitemid 28101752)
41. Corthay A, Bäcklund J, Broddefalk J, et al. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur J Immunol 1998;28:2580-2590 (Pubitemid 28362732)
42. Michaëlsson E, Malmström V, Reis S, Engström A, Burkhardt H, Holmdahl R. T cell recognition of carbohydrates on type II collagen. J Exp Med 1994; 180:745-749
43. Anderton SM. Post-translational modifications of self antigens: implications for autoimmunity. Curr Opin Immunol 2004;16:753-758 (Pubitemid 39423665)